Immix Biopharma Inc (IMMX)
1.56
-0.03
(-1.89%)
USD |
NASDAQ |
Sep 27, 16:00
1.50
-0.06
(-3.85%)
After-Hours: 20:00
Immix Biopharma Shareholders Equity (Quarterly): 23.89M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 23.89M |
| March 31, 2024 | 27.92M |
| December 31, 2023 | 16.41M |
| September 30, 2023 | 19.77M |
| June 30, 2023 | 13.23M |
| March 31, 2023 | 11.77M |
| December 31, 2022 | 13.16M |
| Date | Value |
|---|---|
| September 30, 2022 | 16.75M |
| June 30, 2022 | 18.11M |
| March 31, 2022 | 19.65M |
| December 31, 2021 | 17.99M |
| September 30, 2021 | -6.196M |
| June 30, 2021 | -5.851M |
| December 31, 2020 | -4.731M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-6.196M
Minimum
Sep 2021
27.92M
Maximum
Mar 2024
12.99M
Average
16.58M
Median
Shareholders Equity (Quarterly) Benchmarks
| CEL-SCI Corp | 8.473M |
| AIM ImmunoTech Inc | 6.102M |
| IGC Pharma Inc | 7.88M |
| NovaBay Pharmaceuticals Inc | -0.617M |
| Protalix BioTherapeutics Inc | 28.58M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 28.84M |
| Total Liabilities (Quarterly) | 4.945M |